Artivion, Inc.
General ticker "AORT" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $1.4B (TTM average)
Artivion, Inc. follows the US Stock Market performance with the rate: 61.2%.
Estimated limits based on current volatility of 1.4%: low 45.30$, high 46.63$
Factors to consider:
- Total employees count: 1600 (+6.7%) as of 2024
- US accounted for 48.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Cybersecurity threats, Geopolitical risks, Regulatory and compliance, Labor/talent shortage/retention, Operational and conduct risks
- Current price 24.8% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [22.83$, 36.38$]
- 2025-12-31 to 2026-12-31 estimated range: [22.65$, 36.47$]
Financial Metrics affecting the AORT estimates:
- Negative: with PPE of -203.6 at the end of fiscal year the price was very high
- Positive: 7.86 < Operating profit margin, % of 10.01
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of -1.17 <= -0.75
- Positive: Interest expense per share per price, % of 2.88 <= 3.41
- Positive: -4.48 < Investing cash flow per share per price, % of -2.37
- Positive: 18.93 < Shareholder equity ratio, % of 35.00 <= 41.86
- Positive: -2.95 < Return on assets ratio (scaled to [-100,100]) of -1.66
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
Short-term AORT quotes
Long-term AORT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $313.79MM | $368.25MM | $388.54MM |
| Operating Expenses | $307.59MM | $362.51MM | $349.66MM |
| Operating Income | $6.20MM | $5.74MM | $38.87MM |
| Non-Operating Income | $-21.18MM | $-27.33MM | $-46.39MM |
| Interest Expense | $18.22MM | $25.30MM | $34.28MM |
| R&D Expense | $38.88MM | $28.71MM | $28.45MM |
| Income(Loss) | $-14.98MM | $-21.59MM | $-7.51MM |
| Taxes | $4.21MM | $9.10MM | $5.84MM |
| Profit(Loss)* | $-19.19MM | $-30.69MM | $-13.36MM |
| Stockholders Equity | $284.33MM | $281.78MM | $276.20MM |
| Inventory | $74.48MM | $81.98MM | $79.77MM |
| Assets | $762.80MM | $792.40MM | $789.10MM |
| Operating Cash Flow | $-5.15MM | $18.82MM | $22.24MM |
| Capital expenditure | $10.71MM | $7.43MM | $11.19MM |
| Investing Cash Flow | $-10.71MM | $-0.50MM | $-28.19MM |
| Financing Cash Flow | $-1.64MM | $0.86MM | $2.20MM |
| Earnings Per Share** | $-0.48 | $-0.75 | $-0.32 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.